The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5' CpG island of mucin in cancer cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Yokoyama, Seiya ^a   Kitamoto, Sho ^a   Yamada, Norishige ^a   Houjou, Izumi ^a   Sugai, Tamotsu ^b   Nakamura, Shin ichi ^c   Arisaka, Yoshifumi ^d   Takaori, Kyoichi ^e   Higashi, Michiyo ^a   Yonezawa, Suguru ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c DPR Co LTD   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; Colonic crypt; DNA methylation pattern; Epigenetics; Mucin; Pancreatic juice

Indexed keywords

BISULFITE; GENOMIC DNA; MESSENGER RNA; MUCIN; MUCIN 1; MUCIN 17; MUCIN 2; MUCIN 3A; MUCIN 4; MUCIN 5AC; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA DETERMINATION; DNA FLANKING REGION; DNA METHYLATION; ELECTROPHORESIS; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CRYPT; LIMIT OF DETECTION; METHYLATION SPECIFIC ELECTROPHORESIS; MUCIN 1 GENE; MUCIN GENE; PANCREAS JUICE; POLYMERASE CHAIN REACTION; PREDICTION; PROMOTER REGION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TUMOR GENE;

BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; CPG ISLANDS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MUCINS; NEOPLASMS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; SULFITES;

EID: 84857021124     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-67     Document Type: Article

References (26)

1. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4(7):844-847. 10.1038/nm0798-844, 9662379.
2. Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Goto M, Batra SK, Yonezawa S. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression. Glycobiology 2011, 21(2):247-256. 10.1093/glycob/cwq155, 3010767, 20926598.
3. Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Van Seuningen I. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 2007, 26(45):6566-6576. 10.1038/sj.onc.1210479, 17471237.
4. Yamada N, Nishida Y, Yokoyama S, Tsutsumida H, Houjou I, Kitamoto S, Goto M, Higashi M, Yonezawa S. Expression of MUC5AC, an early marker of pancreatobiliary cancer, is regulated by DNA methylation in the distal promoter region in cancer cells. J Hepatobiliary Pancreat Sci 2010, 17(6):844-854. 10.1007/s00534-010-0278-0, 20734208.
5. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 2008, 8(16):3329-3341. 10.1002/pmic.200800040, 18651706.
6. Hamada T, Goto M, Tsutsumida H, Nomoto M, Higashi M, Sugai T, Nakamura S, Yonezawa S. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing. Cancer Lett 2005, 227(2):175-184. 10.1016/j.canlet.2004.11.058, 16112420.
7. Yamada N, Nishida Y, Tsutsumida H, Hamada T, Goto M, Higashi M, Nomoto M, Yonezawa S. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells. Cancer Res 2008, 68(8):2708-2716. 10.1158/0008-5472.CAN-07-6844, 18413738.
8. Yamada N, Hamada T, Goto M, Tsutsumida H, Higashi M, Nomoto M, Yonezawa S. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int J Cancer 2006, 119(8):1850-1857. 10.1002/ijc.22047, 16721789.
9. Yamada N, Nishida Y, Tsutsumida H, Goto M, Higashi M, Nomoto M, Yonezawa S. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. Br J Cancer 2009, 100(2):344-351. 10.1038/sj.bjc.6604845, 2634723, 19127263.
10. Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Yonezawa S. Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. Biochem Biophys Res Commun 2010, 397(2):333-339. 10.1016/j.bbrc.2010.05.124, 20510874.
11. Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from?. Cancer Sci 2005, 96(4):206-211. 10.1111/j.1349-7006.2005.00035.x, 15819717.
12. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005, 5(3):223-231. 10.1038/nrc1571, 15719030.
13. Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 2005, 11(11):4037-4043. 10.1158/1078-0432.CCR-04-2446, 15930338.
14. Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 2005, 11(3):1219-1225.
15. Hiraki M, Kitajima Y, Sato S, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer. World J Gastroenterol 2010, 16(3):330-338. 10.3748/wjg.v16.i3.330, 2807953, 20082478.
16. Klump B, Hsieh CJ, Dette S, Holzmann K, Kiebetalich R, Jung M, Sinn U, Ortner M, Porschen R, Gregor M. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease. Clin Cancer Res 2003, 9(5):1773-1778.
17. Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Goke B, Lamerz R, Kolligs FT. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 2005, 3(2):142-149. 10.1016/S1542-3565(04)00624-X, 15704048.
18. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, Yeo CJ, Kalloo A, Hruban R, Goggins M. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006, 66(2):1208-1217. 10.1158/0008-5472.CAN-05-2664, 16424060.
19. Aggerholm A, Guldberg P, Hokland M, Hokland P. Extensive intra--and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res 1999, 59(2):436-441.
20. Sugai T, Takahashi H, Habano W, Nakamura S, Sato K, Orii S, Suzuki K. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. J Pathol 2003, 200(2):168-176. 10.1002/path.1340, 12754737.
21. Nakamura S, Goto J, Kitayama M, Kino I. Application of the crypt-isolation technique to flow-cytometric analysis of DNA content in colorectal neoplasms. Gastroenterology 1994, 106(1):100-107.
22. Habano W, Sugai T, Nakamura S, Yoshida T. A novel method for gene analysis of colorectal carcinomas using a crypt isolation technique. Lab Invest 1996, 74(5):933-940.
23. Shinozuka N, Okada K, Torii T, Hirooka E, Tabuchi S, Aikawa K, Tawara H, Ozawa S, Ogawa N, Miyazawa M, et al. Endoscopic pancreatic duct drainage and stenting for acute pancreatitis and pancreatic cyst and abscess. J Hepatobiliary Pancreat Surg 2007, 14(6):569-574. 10.1007/s00534-006-1203-4, 18040622.
24. Schafer H, Servais P, Muyzer G. Successional changes in the genetic diversity of a marine bacterial assemblage during confinement. Arch Microbiol 2000, 173(2):138-145. 10.1007/s002039900121, 10795685.
25. Yonezawa S, Kitajima S, Higashi M, Osako M, Horinouchi M, Yokoyama S, Kitamoto S, Yamada N, Tamura Y, Shimizu T, et al. A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach. Gastric Cancer 2012, published online DOI 10.1007/s10120-011-0125-2.
26. Li M, Chen WD, Papadopoulos N, Goodman SN, Bjerregaard NC, Laurberg S, Levin B, Juhl H, Arber N, Moinova H, et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009, 27(9):858-863. 10.1038/nbt.1559, 2847606, 19684580.